אינפנריקס הקסא
Country: Իսրայել
language: եբրայերեն
source: Ministry of Health
documentation_request_send
active_ingredient:
DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); HAEMOPHILUS B; HEPATITIS B VACCINES; PERTACTIN; PERTUSSIS TOXOID (PT); POLIOVIRUS TYPE 1 INACTIVATED; POLIOVIRUS TYPE 2 INACTIVATED; POLIOVIRUS TYPE 3 INACTIVATED; TETANUS TOXOID
MAH:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC_code:
J07CA
pharmaceutical_form:
אבקה ותרחיף להכנת תרחיף להזרקה
composition:
FILAMENTOUS HAEMAGGLUTININ (FHA) 25 MCG/DOSE; DIPHTHERIA TOXOID NLT 30 IU/DOSE; TETANUS TOXOID NLT 40 IU/DOSE; HEPATITIS B VACCINES 10 MCG/DOSE; POLIOVIRUS TYPE 1 INACTIVATED 40 DU/DOSE; POLIOVIRUS TYPE 2 INACTIVATED 8 DU/DOSE; POLIOVIRUS TYPE 3 INACTIVATED 32 DU/DOSE; HAEMOPHILUS B 10 MCG/DOSE; PERTACTIN 8 MCG/DOSE; PERTUSSIS TOXOID (PT) 25 MCG/DOSE
administration_route:
תוך-שרירי
prescription_type:
מרשם נדרש
manufactured_by:
GLAXO SMITH KLINE BIOLOGICALS S.A
therapeutic_group:
BACTERIAL AND VIRAL VACCINES, COMBINED
therapeutic_indication:
Infantix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by haemophilus influenza type b.
authorization_date:
2020-07-31
